Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
36
pubmed:dateCreated
2006-12-20
pubmed:abstractText
Human papillomavirus (HPV) DNA tumors actively integrating the E6 and E7 oncogenes have a distinct biologic behavior resulting in a more favorable prognosis. To which extent the viral integration by itself, and/or the associated wild-type (wt) TP53 status, and/or a functional p16 contribute to prognosis is unclear.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
20
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5630-6
pubmed:meshHeading
pubmed-meshheading:17179101-Adult, pubmed-meshheading:17179101-Aged, pubmed-meshheading:17179101-Carcinoma, Squamous Cell, pubmed-meshheading:17179101-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:17179101-DNA, Viral, pubmed-meshheading:17179101-DNA Mutational Analysis, pubmed-meshheading:17179101-Female, pubmed-meshheading:17179101-Follow-Up Studies, pubmed-meshheading:17179101-Genes, p16, pubmed-meshheading:17179101-Genes, p53, pubmed-meshheading:17179101-Humans, pubmed-meshheading:17179101-Male, pubmed-meshheading:17179101-Middle Aged, pubmed-meshheading:17179101-Neoplasm Recurrence, Local, pubmed-meshheading:17179101-Neoplasms, Second Primary, pubmed-meshheading:17179101-Oropharyngeal Neoplasms, pubmed-meshheading:17179101-Papillomaviridae, pubmed-meshheading:17179101-Papillomavirus Infections, pubmed-meshheading:17179101-Prognosis, pubmed-meshheading:17179101-Risk Factors, pubmed-meshheading:17179101-Survival Analysis
pubmed:year
2006
pubmed:articleTitle
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
pubmed:affiliation
Head and Neck Cancer Medical Oncology Unit, Medical Statistics and Biometry, Department of Head and Neck Surgery, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. lisa.licitra@istitutotumori.mi.it
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't